ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,378,000 | -15.7% | 191,170 | -7.2% | 1.74% | -19.9% |
Q3 2016 | $2,820,000 | +30.1% | 206,010 | -29.8% | 2.17% | +33.4% |
Q2 2016 | $2,168,000 | +4.5% | 293,352 | -9.6% | 1.62% | +19.6% |
Q1 2016 | $2,074,000 | -29.6% | 324,636 | -31.2% | 1.36% | +11.7% |
Q4 2015 | $2,947,000 | -13.0% | 471,516 | -18.7% | 1.22% | -2.2% |
Q3 2015 | $3,386,000 | -46.5% | 579,719 | -24.3% | 1.24% | -14.6% |
Q2 2015 | $6,330,000 | -24.0% | 765,415 | -24.3% | 1.46% | -5.6% |
Q1 2015 | $8,330,000 | +18.9% | 1,010,864 | -0.8% | 1.54% | +20.8% |
Q4 2014 | $7,003,000 | +94.1% | 1,019,324 | +52.5% | 1.28% | +95.6% |
Q3 2014 | $3,608,000 | -9.7% | 668,220 | +6.5% | 0.65% | +2.5% |
Q2 2014 | $3,997,000 | -19.7% | 627,480 | +1.6% | 0.64% | -11.8% |
Q1 2014 | $4,976,000 | +20.8% | 617,387 | +2.2% | 0.72% | +26.0% |
Q4 2013 | $4,119,000 | -61.2% | 603,949 | +4.6% | 0.57% | -65.6% |
Q3 2013 | $10,620,000 | +7.3% | 577,195 | +2.0% | 1.67% | -5.1% |
Q2 2013 | $9,899,000 | – | 565,956 | – | 1.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
Geduld E E | 272,200 | $1,470,000 | 1.04% |
Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |